Revision history of "ACETYL SALICYLIC ACID AND PLATELETS IN COLON CANCER." (Q3177778)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 23:0023:00, 9 October 2024DG Regio talk contribs 77,415 bytes +5 Changed label, description and/or aliases in pt
  • curprev 23:0023:00, 9 October 2024DG Regio talk contribs 77,410 bytes +73 Set a claim value: summary (P836): Baixa dose de ácido acetil salicílico (AAS) impede o desenvolvimento e progressão do cancro colorretal (CCR), um processo associado com a sobre-expressão de COX-2. O AAS parece ser o candidato ideal na quimioprevenção do CCR. As entidades reguladoras devem conhecer os mecanismos de ação antes de aprovarem a sua indicação. A nossa hipótese é que o seu efeito se deve principalmente ao efeito antiplaquetário. Objetivo principal: Verifique se o AAS prov...

20 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 11:1511:15, 4 August 2022DG Regio talk contribs 76,064 bytes +52,436 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 19:2219:22, 12 October 2021DG Regio talk contribs 12,656 bytes +2,422 Created claim: summary (P836): Low-dose acetyl salicylic acid (AAS) prevents the development and progression of colorectal cancer (CCR), a process associated with over-expression of COX-2. The AAS seems to be the ideal candidate in CCR chemo-prevention. Regulatory agencies need to know the mechanisms for action before approving their indication. Our hypothesis is that its effect is mainly due to the antiplatelet effect. Primary objective: Check if the AAS causes acetylation (...
  • curprev 19:2219:22, 12 October 2021DG Regio talk contribs 10,234 bytes −2,422 Removed claim: summary (P836): Low-dose acetyl salicylic acid (AAS) prevents the development and progression of colorectal cancer (CCR), a process associated with over-expression of COX-2. The AAS seems to be the ideal candidate in CCR chemo-prevention. Regulatory agencies need to know the mechanisms for action before approving their indication. Our hypothesis is that its effect is mainly due to the antiplatelet effect. Primary objective: Check if the AAS causes acetylation...
  • curprev 18:5818:58, 12 October 2021DG Regio talk contribs 12,656 bytes +111 Changed label, description and/or aliases in en: translated_label
  • curprev 18:5818:58, 12 October 2021DG Regio talk contribs 12,545 bytes +2,422 Created claim: summary (P836): Low-dose acetyl salicylic acid (AAS) prevents the development and progression of colorectal cancer (CCR), a process associated with over-expression of COX-2. The AAS seems to be the ideal candidate in CCR chemo-prevention. Regulatory agencies need to know the mechanisms for action before approving their indication. Our hypothesis is that its effect is mainly due to the antiplatelet effect. Primary objective: Check if the AAS causes acetylation (...

10 October 2021

9 October 2021

8 October 2021